MECIKO A MUHAREMOVIC
Allopathic & Osteopathic Physicians|Internal Medicine HAMPTON BAYS, NY NPI 1477640969
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$8,873.44
- Category: General Payments
- Program years: PY2018–2024
- Record count: 448
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,476.75 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,476.75 | 63 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $233.73 | 8 |
| PFIZER INC. | $132.04 | 7 |
| Lilly USA, LLC | $120.38 | 5 |
| Amgen Inc. | $101.10 | 4 |
| Alkermes, Inc. | $96.00 | 4 |
| Abbott Laboratories | $94.56 | 5 |
| Exact Sciences Corporation | $84.53 | 3 |
| Indivior Inc. | $74.34 | 3 |
| Regeneron Healthcare Solutions, Inc. | $72.12 | 3 |
| Amneal Pharmaceuticals LLC | $70.61 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.92 | 4 |
| GENZYME CORPORATION | $59.33 | 2 |
| ABBVIE INC. | $47.75 | 2 |
| Janssen Pharmaceuticals, Inc | $45.53 | 2 |
| Novo Nordisk AS | $41.31 | 2 |
| Astellas Pharma US Inc | $29.15 | 1 |
| Otsuka America Pharmaceutical, Inc. | $25.34 | 1 |
| Avvisto Therapeutics, LLC | $22.66 | 1 |
| GlaxoSmithKline, LLC. | $22.10 | 1 |
| Merck Sharp & Dohme Corporation | $17.95 | 1 |
| Orexo US, Inc. | $16.30 | 1 |
By program year
Records — PY2024 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.